PFE stock decreased 30.0% from a peak of $40.71 on January 23, 2020, to $28.49 on March 23, 2020, compared to a ...

Pfizer delivered a significant earnings surprise in its third-quarter results, demonstrating the pharmaceutical giant’s resilience amid a challenging year for its stock performance. The company’s ...

Pfizer’s School of Science Mobile Experience rolled into McPherson this week, offering local students a one-of-a-kind opportunity to explore the wonders of science through immersive, hands-on learning ...

New Chairman Joins Entera’s Board with Senior Global Leadership Experience from Pfizer, Wyeth and Other Leading Biopharma ...

Pfizer's recent issues include poor financial results, looming patent cliffs, and the potential impact of tariffs. The company is addressing these issues by developing new medicines and negotiating ...

Pfizer's third-quarter sales fell 6% year over year to $16.65 billion, beating the consensus of $16.59 billion. The revenue reflected an operational decline of 7%. The operational decrease was ...

The shares of Pfizer Inc (NYSE:PFE) were last seen up 4.9% to trade at $24.4, after the pharmaceutical giant's second-quarter results beat expectations. The company also lifted its 2025 profit outlook ...